Biomacromolecules from bio-waste fractions for high added value applications The main objective of DAFIA is to exploit the organic fraction of municipal solid wastes (MSW) and marine rest raw materials (MRRM) as feedstocks for higher value products. Municipal solids wastes represents more than 500 kg/capita (EU-27 average) and 300 million tonnes overall every year in […]
DuPont Industrial Biosciences has been awarded a grant from the European Commission to demonstrate high-efficiency enzyme production to increase biogas yields as part of the DEMETER project, funded from the Bio Based Industries Joint Undertaking under the European Union’s Horizon 2020 Research and Innovation program.
Demeter: Demonstrating more efficient enzyme production to increase biogas yields.
DEMETER will increase the yield of the fermentation process at an industrial scale as well as the down-stream processing of a C1-based biogas enzyme, reducing the cost of the end product and making the enzyme available for wide-spread application in biogas production throughout Europe.
Novel, sustainable marine bio-surfactant/bio-emulsifier for commercial exploitation Surfactants and emulsifiers are surface-active (SA) performance molecules used in a wide variety of applications in households, industry and agriculture. Industry is looking to replacing many of its synthetic SA ingredients, with more sustainable, natural and eco-friendly counterparts. Microbially-derived SAs offer a viable solution as they can be […]
The CARBOSURF project aims to develop new biobased processes as well as products and solves bottlenecks in the fermentative production of biobased biosurfactants and specialty carbohydrates. Specifically, it targets different glycolipid biosurfactants with a wide range of application fields and specialty carbohydrates, i.e. complex Human Milk Oligosaccharides that find applications as neutraceutical, pharmaceutical and cosmetic ingredients. The project is coordinated by Prof. Soetaert from Ghent University (Belgium).
Sugar beet pulp (SBP) accounts for approx. 13 million tonnes in Europe and is a major residual stream from the sugar beet industry, which is currently valorised as low value feed and/or green gas. In order to increase the value of its side streams, PULP2VALUE developed multiple extraction techniques to isolate more valuable products from this large fraction of sugar beet pulp.
2G BIOPIC proposes a new approach: bioethanol production from lignocellulosic biomass. This technology is based on a highly effective clean deconstruction of lignocellulosic biomass, an advanced organosolv technology, for which several patents have been submitted in the past decade by CIMV. An original and efficient biomass refining technology allows optimal extraction of the three main biomass components and downstream biotechnological transformation.
The RenewPACK project will demonstrate the material Skalax as a barrier in food packaging for the first time ever. RenewPACK is a project partly financed by the European Commission through LIFE+. The project is conducted by Xylophane AB (as coordinating beneficiary) and Bio Base Europe Pilot Plant (as associated beneficiary).
IB2Market aims to bring industrial biotechnology from the research lab to the market and to solve the bottle-necks in industrialization. The project covers process development, scale up, market exploration and the drafting of a valorization plan to support a successful market introduction.
The Nano3Bio project aims to develop biotechnological production systems for nanoformulated chitosans. Chitosans are among the most versatile and most promising biopolymers and have excellent physico-chemical and material properties as well as a wide range of biological functionalities.
The VISIONS project aims to identify the main organic waste streams and by-products in Flanders with the ambition to use these products in new value chains.
The project, a CINBIOS* initiative, is financially supported by the Flemish Agency for Innovation by Science and Technology (IWT). It is co-funded by a large consortium of companies interested in either valorising their waste stream or in finding alternative feedstocks for biobased processes. This consortium is monitoring and steering the project’s progress.
The project aims to accelerate the growth of the biobased economy, EU and local partners joined forces by providing financial, technological, training, networking and political support to enterprises in North West Europe (NWE) innovating in biobased products and processes.
This project aims to create new-to-nature and tailor-made biosurfactants through metabolic engineering of the unconventional yeast Starmerella bombicola.
Surfactants or surface active agents are applied in a wide range of industries and products e.g. cleaning, personal care, cosmetics, agriculture, oil recovery, paper industry. Surfactants are produced in large amounts of which the majority is used in households for laundry and cleaning. This results in large volumes of waste water ending up in the environment.
The ChitoBioEngineering project aims at establishing biotechnological ways of producing fully defined, partially acetylated chitosan oligomers. This will be achieved through genetic, metabolic, and enzyme engineering.
Industrial biotechnology plays a crucial role in the development of sustainable and cost effective production processes for biobased chemicals. These processes typically consist of two distinct unit operations: fermentation, followed by purification of the compound of interest from the fermentation broth. Product recovery and purification (also called downstream processing or DSP) are important cost factors, responsible for up to 80% of the total production cost. Reducing DSP cost is therefore a key success factor to improve the overall economics of biobased processes.
The goal of the Novosides project is the development of biocatalytic processes for the glycosylation of small organic molecules such as flavonoids, alkaloids and steroids. Glycosylation can drastically improve both the physicochemical and biological properties of these molecules (e.g. slow release, improved solubility and stability, taste modification, drug targeting), but few biocatalysts are currently available to perform this modification cost-efficiently at industrial scale.